Indivisible Partners’s AbbVie ABBV Stock Holding History

Indivisible Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.24M	Buy	12,876 +2,526	+24%	+$543K	0.18%	101
2026 Q1	$2.25M	Buy	10,350 +780	+8%	+$173K	0.2%	90
2025 Q4	$2.19M	Buy	+9,570	New	+$2.18M	0.24%	78

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Indivisible Partners's ABBV Position: Q2 2026 in Review

Indivisible Partners increased its AbbVie (ABBV) stake by 24% in Q2 2026, buying an estimated $543K and bringing the position to 12,876 shares worth $3.24M. The position accounts for 0.18% of the portfolio, ranked #101.

Indivisible Partners first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Indivisible Partners held 12,876 shares of AbbVie worth $3.24M as of Q2 2026.
Indivisible Partners bought 2,526 AbbVie shares in Q2 2026, an estimated $543K.
AbbVie made up 0.18% of Indivisible Partners's portfolio in Q2 2026, its #101 holding.
Indivisible Partners first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Indivisible Partners's 13F filing for Q2 2026, filed 4 Aug 2026.